Current Clinical Research Recruitment

Leading the Way in Clinical Research

Our highly skilled and dedicated research team is pleased to announce that we are currently recruiting patients for the following studies.

Regeneron: Designed for diabetic retinopathy patients by using intravitreal injection of a anti-VEGF product. To join the study, patients must

  • Have type 1 or type 2 diabetes mellitus 
  • Be confirmed to have moderately severe to severe nonproliferative diabetic retinopathy

Roche: A Phase 2 study to evaluate an investigational product to treat patients with neovascularization secondary to AMD. To join the study, patients must be

  • Treatment-naive with subfoveal or juxtafoveal wet AMD (no prior treatment for CNV) with subfoveal fluid or hemorrhage. 
  • Best corrected viasual acuity 20/50 to 20/320 (Inclusive) Snellen

For more information, please contact Dr. John Olson or Sherrie Cox: 
800.255.7188 // clinicalresearch@cfretina.com